Unraveling the Role of Heme in Neurodegeneration
暂无分享,去创建一个
S. Petrillo | E. Tolosano | D. Chiabrando | Veronica Fiorito | Deborah Chiabrando | Veronica Fiorito | Sara Petrillo | Emanuela Tolosano | V. Fiorito
[1] V. Ganapathy,et al. Polarized distribution of heme transporters in retinal pigment epithelium and their regulation in the iron-overload disease hemochromatosis. , 2011, Investigative ophthalmology & visual science.
[2] M. Wésolowski-Louvel,et al. Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. , 1998, Journal of molecular biology.
[3] B. Paw,et al. Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins , 2008, Nature.
[4] Hiroshi Suzuki,et al. Heme regulates gene expression by triggering Crm1‐dependent nuclear export of Bach1 , 2004, The EMBO journal.
[5] B. Stockwell,et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.
[6] M. Pérez,et al. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease , 2015, Oxidative medicine and cellular longevity.
[7] W. Berger,et al. Next generation sequencing based identification of disease-associated mutations in Swiss patients with retinal dystrophies , 2016, Scientific Reports.
[8] J. Abkowitz,et al. A Heme Export Protein Is Required for Red Blood Cell Differentiation and Iron Homeostasis , 2008, Science.
[9] Oxidative stress and cellular pathologies in Parkinson’s disease , 2017, Molecular Brain.
[10] Ann Smith,et al. Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states , 2013, Journal of neurochemistry.
[11] L. Carneiro,et al. Protein aggregation as a cellular response to oxidative stress induced by heme and iron , 2016, Proceedings of the National Academy of Sciences.
[12] M. Muckenthaler,et al. Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position −7007 of the FPN1 promoter , 2010, Haematologica.
[13] N. Verpoorten,et al. Disease mechanisms in hereditary sensory and autonomic neuropathies , 2006, Neurobiology of Disease.
[14] W. Frey,et al. A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Mellgren,et al. Familial amyotrophic lateral sclerosis , 1980 .
[16] E. Masliah,et al. Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro , 1999 .
[17] K. Choi,et al. Paraptosis in the anti-cancer arsenal of natural products. , 2016, Pharmacology & therapeutics.
[18] M. Beal,et al. Mitochondrial dysfunction in Parkinson's disease , 2016, Journal of neurochemistry.
[19] S. Tortorelli,et al. Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology , 2013, International journal of dermatology.
[20] Gabriela Kalna,et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase , 2011, Nature.
[21] P. Hemachandra Reddy,et al. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. , 2011, Human molecular genetics.
[22] M. Kiernan,et al. Purple pigments: The pathophysiology of acute porphyric neuropathy , 2011, Clinical Neurophysiology.
[23] P. Dyck,et al. Porphyria and its neurologic manifestations. , 2014, Handbook of clinical neurology.
[24] C. W. Nogueira,et al. δ-Aminolevulinate Dehydratase Activity is Stimulated in a MPTP Mouse Model of Parkinson’s Disease: Correlation with Myeloperoxidase Activity , 2017, Cellular and Molecular Neurobiology.
[25] G. Donmez,et al. Mitochondrial Biology and Neurological Diseases , 2016, Current neuropharmacology.
[26] L. Silengo,et al. Hypoxia controls Flvcr1 gene expression in Caco2 cells through HIF2α and ETS1. , 2014, Biochimica et biophysica acta.
[27] D. Pareyson,et al. Posterior column ataxia with retinitis pigmentosa coexisting with sensory‐autonomic neuropathy and leukemia due to the homozygous p.Pro221Ser FLVCR1 mutation , 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[28] A. Gregory,et al. Neurodegeneration with brain iron accumulation. , 2005, Folia neuropathologica.
[29] Peilin Huang,et al. ABCG2 reduces ROS‐mediated toxicity and inflammation: a potential role in Alzheimer’s disease , 2010, Journal of neurochemistry.
[30] H. Bonkovsky,et al. Clinically Important Features of Porphyrin and Heme Metabolism and the Porphyrias , 2014, Metabolites.
[31] R. Kauppinen,et al. An update of clinical management of acute intermittent porphyria , 2015 .
[32] T. Kawarai,et al. Proteasome impairment in neural cells derived from HMSN-P patient iPSCs , 2017, Molecular Brain.
[33] A. Eklund,et al. GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein , 2008, Proceedings of the National Academy of Sciences.
[34] D. Richardson,et al. Mitochondrial dysfunction in the neuro-degenerative and cardio-degenerative disease, Friedreich's ataxia , 2017, Neurochemistry International.
[35] S. Tsuji,et al. Posterior column ataxia with retinitis pigmentosa in a Japanese family with a novel mutation in FLVCR1 , 2011, neurogenetics.
[36] T. Stemmler,et al. Frataxin and Mitochondrial FeS Cluster Biogenesis* , 2010, The Journal of Biological Chemistry.
[37] L. Silengo,et al. The heme exporter Flvcr1 regulates expansion and differentiation of committed erythroid progenitors by controlling intracellular heme accumulation , 2015, Haematologica.
[38] M. Roussel,et al. Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis. , 2017, JCI Insight.
[39] J. Cowan,et al. Frataxin-mediated Iron Delivery to Ferrochelatase in the Final Step of Heme Biosynthesis* , 2004, Journal of Biological Chemistry.
[40] J. Gal,et al. Mitochondrial dysfunction in amyotrophic lateral sclerosis. , 2010, Biochimica et biophysica acta.
[41] H. Handa,et al. Adenine Nucleotide Translocator Transports Haem Precursors into Mitochondria , 2008, PloS one.
[42] Dyonne T Hartong,et al. Retinitis pigmentosa , 2009 .
[43] K. McNaught,et al. Proteasomal function is impaired in substantia nigra in Parkinson's disease , 2001, Neuroscience Letters.
[44] C. Fallet-Bianco,et al. Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome). , 2010, American journal of human genetics.
[45] M. Beal,et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery , 2008, Proceedings of the National Academy of Sciences.
[46] P. Tsai,et al. A novel TFG mutation causes Charcot-Marie-Tooth disease type 2 and impairs TFG function , 2014, Neurology.
[47] M. Núñez,et al. Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders. , 2015, Mitochondrion.
[48] A. Landar,et al. Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy. , 2012, American journal of physiology. Heart and circulatory physiology.
[49] P. Clouston,et al. A splice-site variant in FLVCR1 produces retinitis pigmentosa without posterior column ataxia , 2018, Ophthalmic genetics.
[50] P. So,et al. The Aging of Iron Man , 2018, Front. Aging Neurosci..
[51] E. Tolosano,et al. Heme and erythropoieis: more than a structural role , 2014, Haematologica.
[52] H. D. de Vries,et al. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? , 2008, Free radical biology & medicine.
[53] S. Al-Karadaghi,et al. The Structure of the Complex between Yeast Frataxin and Ferrochelatase , 2016, The Journal of Biological Chemistry.
[54] R. Morimoto,et al. Proteostasis and the aging proteome in health and disease. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[55] O. Elemento,et al. Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa. , 2010, American journal of human genetics.
[56] M. Ristow,et al. Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells. , 2005, Human molecular genetics.
[57] S. Heinemann,et al. Heme impairs the ball-and-chain inactivation of potassium channels , 2013, Proceedings of the National Academy of Sciences.
[58] J. Abkowitz,et al. Identification of a Human Heme Exporter that Is Essential for Erythropoiesis , 2004, Cell.
[59] D. Richardson,et al. Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant , 2009, Proceedings of the National Academy of Sciences.
[60] C. Tailor,et al. The Fowler Syndrome-Associated Protein FLVCR2 Is an Importer of Heme , 2010, Molecular and Cellular Biology.
[61] R. Lewis,et al. Autosomal recessive posterior column ataxia with retinitis pigmentosa caused by novel mutations in the FLVCR1 gene , 2015, The International journal of neuroscience.
[62] C. Fallet-Bianco,et al. Fowler syndrome—A clinical, radiological, and pathological study of 14 cases , 2010, American journal of medical genetics. Part A.
[63] X. Navarro,et al. Neurotoxicity induced by antineoplastic proteasome inhibitors. , 2014, Neurotoxicology.
[64] F. Vinchi,et al. Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes , 2014, Front. Pharmacol..
[65] R. Gozzelino. The Pathophysiology of Heme in the Brain. , 2016, Current Alzheimer research.
[66] Da-Neng Wang,et al. Ins and outs of major facilitator superfamily antiporters. , 2008, Annual review of microbiology.
[67] L. Silengo,et al. Mutations in the Heme Exporter FLVCR1 Cause Sensory Neurodegeneration with Loss of Pain Perception , 2016, PLoS genetics.
[68] J. Dichgans,et al. Oxidative stress in patients with Friedreich ataxia , 2000, Neurology.
[69] A. Audhya,et al. Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure , 2013, Proceedings of the National Academy of Sciences.
[70] D. Winge,et al. Structure, function, and assembly of heme centers in mitochondrial respiratory complexes. , 2012, Biochimica et biophysica acta.
[71] R. Boldrini,et al. Proliferative vasculopathy and hydranencephaly–hydrocephaly syndrome or Fowler syndrome: Report of a family and insight into the disease's mechanism , 2018, Molecular genetics & genomic medicine.
[72] V. Desquiret-Dumas,et al. Acute intermittent porphyria causes hepatic mitochondrial energetic failure in a mouse model. , 2014, The international journal of biochemistry & cell biology.
[73] M. Maines,et al. Overexpression of Heme Oxygenase‐1 Is Neuroprotective in a Model of Permanent Middle Cerebral Artery Occlusion in Transgenic Mice , 1999, Journal of neurochemistry.
[74] P. Buehler,et al. Proteasome inhibition and oxidative reactions disrupt cellular homeostasis during heme stress , 2014, Cell Death and Differentiation.
[75] G. Vanderhoff,et al. REGULATORY ROLE OF HEME * , 1974, Annals of the New York Academy of Sciences.
[76] I. Hamza,et al. Heme Mobilization in Animals: A Metallolipid's Journey. , 2016, Accounts of chemical research.
[77] T. Stemmler,et al. Human frataxin: iron and ferrochelatase binding surface. , 2007, Chemical communications.
[78] F. Han,et al. The role of endoplasmic reticulum stress in neurodegenerative disease , 2016, Apoptosis.
[79] C. Vulpe,et al. Identification of an Intestinal Heme Transporter , 2005, Cell.
[80] A. Martelli,et al. Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation , 2014, Front. Pharmacol..
[81] M. Pook,et al. Animal and cellular models of Friedreich ataxia , 2013, Journal of neurochemistry.
[82] S. Heinemann,et al. Metabolic regulation of potassium channels. , 2004, Annual review of physiology.
[83] P. Lansbury,et al. A century-old debate on protein aggregation and neurodegeneration enters the clinic , 2006, Nature.
[84] M. Maes,et al. The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications , 2018, Molecular Neurobiology.
[85] D. Dexter,et al. Neurodegenerative diseases and therapeutic strategies using iron chelators. , 2015, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[86] J.. Neurodegenerative Diseases , 1996, GWUMC Department of Biochemistry and Molecular Biology Annual Spring Symposia.
[87] I. Paulsen,et al. Major Facilitator Superfamily , 1998, Microbiology and Molecular Biology Reviews.
[88] D. Manners,et al. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[89] A. Nordgren,et al. Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy , 2016, Clinical genetics.
[90] Emma Lloyd Raven,et al. The regulatory role of heme in neurons. , 2011, Metallomics : integrated biometal science.
[91] E. Tolosano,et al. Mitochondrial Targeting in Neurodegeneration: A Heme Perspective , 2018, Pharmaceuticals.
[92] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[93] P. Patel,et al. Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.
[94] L. Lue,et al. ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40 Peptides , 2009, The Journal of Neuroscience.
[95] C. B. Pickett,et al. The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress* , 2009, Journal of Biological Chemistry.
[96] Peilin Huang,et al. Abcg2 deficiency augments oxidative stress and cognitive deficits in Tg‐SwDI transgenic mice , 2012, Journal of neurochemistry.
[97] M. Castro‐Gago,et al. Congenital Hydranencephalic-Hydrocephalic Syndrome Associated With Mitochondrial Dysfunction , 1999, Journal of child neurology.
[98] L. Scorrano,et al. Shaping the role of mitochondria in the pathogenesis of Huntington's disease , 2012, The EMBO journal.
[99] L. Silengo,et al. Supplemental Material and Methods , 2014 .
[100] M. Fleming,et al. HRG1 is essential for heme transport from the phagolysosome of macrophages during erythrophagocytosis. , 2013, Cell metabolism.
[101] H. Atamna. Heme binding to Amyloid-β peptide: Mechanistic role in Alzheimer's disease , 2006 .
[102] T. Rouault,et al. Biogenesis and functions of mammalian iron-sulfur proteins in the regulation of iron homeostasis and pivotal metabolic pathways , 2017, The Journal of Biological Chemistry.
[103] Youn-Hee Choi,et al. Repression of adenosine triphosphate–binding cassette transporter ABCG2 by estrogen increases intracellular glutathione in brain endothelial cells following ischemic reperfusion injury , 2018, Neurobiology of Aging.
[104] K. Bürk. Friedreich Ataxia: current status and future prospects , 2017, Cerebellum & Ataxias.
[105] A. Eschalier,et al. Potassium channels in neuropathic pain: advances, challenges, and emerging ideas , 2016, Pain.
[106] Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage , 2015, Journal of Neuroinflammation.
[107] F. Supek,et al. Transcriptional control of AAC3 gene encoding mitochondrial ADP/ATP translocator in Saccharomyces cerevisiae by oxygen, heme and ROX1 factor. , 1993, European journal of biochemistry.
[108] T. Schwarz. Mitochondrial trafficking in neurons. , 2013, Cold Spring Harbor perspectives in biology.
[109] Xifu Wang,et al. Induction of heme oxygenase-1 with hemin attenuates hippocampal injury in rats after acute carbon monoxide poisoning. , 2009, Toxicology.
[110] J. Abkowitz,et al. Kinetics and Specificity of Feline Leukemia Virus Subgroup C Receptor (FLVCR) Export Function and Its Dependence on Hemopexin* , 2010, The Journal of Biological Chemistry.
[111] G. Gyapay,et al. High‐throughput sequencing of a 4.1 Mb linkage interval reveals FLVCR2 deletions and mutations in lethal cerebral vasculopathy , 2010, Human mutation.
[112] K. Janssens,et al. Mechanisms of disease in hereditary sensory and autonomic neuropathies , 2012, Nature Reviews Neurology.
[113] S. Heinemann,et al. Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels , 2003, Nature.
[114] C. Shaw,et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. , 2007, Human molecular genetics.
[115] M. Hentze,et al. Iron regulatory protein 1 sustains mitochondrial iron loading and function in frataxin deficiency. , 2015, Cell metabolism.
[116] R. Lill,et al. Iron–sulfur cluster biogenesis and trafficking in mitochondria , 2017, The Journal of Biological Chemistry.
[117] Nada Jabado,et al. Unexpected allelic heterogeneity and spectrum of mutations in Fowler syndrome revealed by next‐generation exome sequencing , 2010, Human mutation.
[118] L. Silengo,et al. Crucial Role of FLVCR1a in the Maintenance of Intestinal Heme Homeostasis. , 2015, Antioxidants & redox signaling.
[119] M. Zeviani,et al. Syndromic parkinsonism and dementia associated with OPA 1 missense mutations , 2015, Annals of neurology.
[120] D. Ito,et al. TFG-Related Neurologic Disorders: New Insights Into Relationships Between Endoplasmic Reticulum and Neurodegeneration , 2016, Journal of neuropathology and experimental neurology.
[121] Jose A. Santiago,et al. Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson’ Disease , 2017, Front. Aging Neurosci..
[122] N. Hirokawa,et al. The Molecular Motor KIF1A Transports the TrkA Neurotrophin Receptor and Is Essential for Sensory Neuron Survival and Function , 2016, Neuron.
[123] I. Katona,et al. Regulation of endoplasmic reticulum turnover by selective autophagy , 2015, Nature.
[124] M. Castro‐Gago,et al. Congenital Hydranencephalic-Hydrocephalic Syndrome With Proliferative Vasculopathy: A Possible Relation With Mitochondrial Dysfunction , 2001, Journal of child neurology.
[125] G. Bennett,et al. Mitotoxicity in distal symmetrical sensory peripheral neuropathies , 2014, Nature Reviews Neurology.
[126] S. Schreier,et al. Hemin-induced lipid membrane disorder and increased permeability: a molecular model for the mechanism of cell lysis. , 1993, Archives of biochemistry and biophysics.
[127] C. Peers,et al. Oxidative modulation of K+ channels in the central nervous system in neurodegenerative diseases and aging. , 2015, Antioxidants & redox signaling.
[128] C. Righy,et al. Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within? , 2016, Current neuropharmacology.
[129] D. Butterfield,et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia , 2005, Journal of the Neurological Sciences.
[130] G. Merlo,et al. The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation. , 2012, The Journal of clinical investigation.
[131] S. Levi,et al. Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms , 2014, Front. Pharmacol..
[132] W. Richard McCombie,et al. High-Throughput Sequencing , 2011 .
[133] J. Auwerx,et al. Pharmacological approaches to restore mitochondrial function , 2013, Nature Reviews Drug Discovery.
[134] A. Cuervo,et al. Proteostasis and aging , 2015, Nature Medicine.
[135] M. Auer-Grumbach. Hereditary sensory and autonomic neuropathies. , 2013, Handbook of clinical neurology.
[136] T. Grune,et al. Proteasome inhibitors in cancer therapy: Treatment regimen and peripheral neuropathy as a side effect , 2017, Free radical biology & medicine.
[137] J. Li,et al. Oxidative Stress and Neurodegenerative Disorders , 2007, International journal of molecular sciences.
[138] W. Scheper,et al. The unfolded protein response in neurodegenerative diseases: a neuropathological perspective , 2015, Acta Neuropathologica.
[139] G. Merlo,et al. Heme accumulation in endothelial cells impairs angiogenesis by triggering paraptosis , 2017, Cell Death & Differentiation.
[140] D. Morton,et al. Posterior column ataxia with retinitis pigmentosa (AXPC1) maps to chromosome 1q31-q32 , 1999, Neurology.
[141] Sanjay Kumar,et al. Free heme toxicity and its detoxification systems in human. , 2005, Toxicology letters.
[142] K. Anderson,et al. Porphyria Diagnostics—Part 1: A Brief Overview of the Porphyrias , 2015, Current protocols in human genetics.
[143] D. Marmolino. Friedreich's ataxia: Past, present and future , 2011, Brain Research Reviews.
[144] M. Brand,et al. Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[145] Thomas L. Williams,et al. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation. , 2015, Biochemistry.
[146] S. Heinemann,et al. Oxidative modulation of voltage-gated potassium channels. , 2014, Antioxidants & redox signaling.
[147] Xiongwei Zhu,et al. Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease , 2009, Neuroscience Letters.
[148] J. Schuetz,et al. Role of ABCG2/BCRP in biology and medicine. , 2006, Annual review of pharmacology and toxicology.
[149] D. Morton,et al. An autosomal recessive disorder with posterior column ataxia and retinitis pigmentosa , 1997, Neurology.
[150] S. Doré,et al. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. , 2007, Brain : a journal of neurology.
[151] M. Akabas,et al. Identification of an Intestinal Folate Transporter and the Molecular Basis for Hereditary Folate Malabsorption , 2006, Cell.
[152] N. Simon,et al. The neurologic manifestations of the acute porphyrias , 2011, Journal of Clinical Neuroscience.
[153] Andreas Bracher,et al. Molecular chaperones in protein folding and proteostasis , 2011, Nature.